Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer-Reference-Cited by-同舟云学术

Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer

Published:2014-08-27 Issue:1 Volume:6 Page:75-79
ISSN:2045-435X
Container-title:BMJ Supportive & Palliative Care
language:en
Short-container-title:BMJ Support Palliat Care

Author:

Landers Amanda,Muircroft Wendy,Brown Helen

Publisher

BMJ

Subject

Medical–Surgical,Oncology(nursing),General Medicine,Medicine (miscellaneous)

Reference26 articles.

1. Cancer Research UK [Internet]. Twenty most common causes of cancer death. 2011. http://www.cancerresearchuk.org/cancer-info/cancerstats/mortality/cancerdeaths/#Twenty (accessed Oct 2013).

2. National Cancer Institute [Internet]. Bethesda; SEER Cancer Statistics Review, 1975–2006; 2009 [cited 24 May 2013]. http://srab.cancer.gov/joinpoint

3. Pancreatic cancer: surgical management and outcomes after 6 years of follow-up;Speer;Med J Aust,2012

4. Management of adenocarcinoma of the body and tail of the pancreas;Brennan;Ann Surg,1996

5. Recent advances in clinical practice—biology and management of pancreatic cancer;Ghaneh;Gut,2007

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma;Cancers;2023-12-08

2. Comprehensive, long-term evaluation of pancreatic exocrine insufficiency after pancreatoduodenectomy;Pancreatology;2023-12

3. Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer;Cancers;2023-11-25

4. A National Audit of Pancreatic Enzyme Prescribing in Pancreatic Cancer from 2015 to 2023 in England Using OpenSAFELY-TPP;Seminars in Oncology Nursing;2023-06

5. Recent Advances in Pancreatic Ductal Adenocarcinoma: Strategies to Optimise the Perioperative Nutritional Status in Pancreatoduodenectomy Patients;Cancers;2023-04-25